Public Library of Science
Browse
pone.0218649.g003.tif (247.59 kB)

Prevalence of total, acquired and ART-adjusted HIV drug resistance.

Download (247.59 kB)
figure
posted on 2019-07-03, 20:05 authored by Ume L. Abbas, Robert L. Glaubius, Yajun Ding, Gregory Hood

A: Prevalence of total drug resistance at 2018. B: Prevalence of total drug resistance by 2030. C: Prevalence of acquired drug resistance mutations by 2030. D: Prevalence of acquired drug-resistant mutants by 2030. E: Prevalence of acquired drug-resistant mutants at 2018. F: ART-adjusted drug resistance prevalence at 2018.

History

Usage metrics

    PLOS ONE

    Categories

    Keywords

    first-line antiretroviral therapyHeterosexual HIV epidemicHIV drug resistancealternative first-line regimensM 184V K 65Rmodeling study Background Tenofovir-containing regimensdrug resistance levelstenofovir-containing first-line ARTNNRTICD 4-based ARTConsiderable HIV drug resistanceIQRdrug resistanceincident infectionsK 65R mutations

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC